Ventyx Biosciences Stock Revenue
| VTYX Stock | USD 1.37 0.04 2.84% |
Ventyx Biosciences fundamentals help investors to digest information that contributes to Ventyx Biosciences' financial success or failures. It also enables traders to predict the movement of Ventyx Stock. The fundamental analysis module provides a way to measure Ventyx Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ventyx Biosciences stock.
| Last Reported | Projected for Next Year |
Ventyx | Revenue |
Ventyx Biosciences Company Revenue Analysis
Ventyx Biosciences' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of Ventyx
Projected quarterly revenue analysis of Ventyx Biosciences provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Ventyx Biosciences match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Ventyx Biosciences' stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Ventyx Biosciences reported 0.0 of revenue. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Ventyx Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ventyx Biosciences' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ventyx Biosciences could also be used in its relative valuation, which is a method of valuing Ventyx Biosciences by comparing valuation metrics of similar companies.Ventyx Biosciences is currently under evaluation in revenue category among its peers.
Ventyx Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Ventyx Biosciences from analyzing Ventyx Biosciences' financial statements. These drivers represent accounts that assess Ventyx Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Ventyx Biosciences' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Enterprise Value | 1.1B | 930.3M | 1.7B | 133.5M | 153.5M | 145.9M |
Ventyx Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Ventyx Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ventyx Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ventyx Biosciences' value.| Shares | Geode Capital Management, Llc | 2024-12-31 | 1.4 M | Millennium Management Llc | 2024-12-31 | 1.3 M | State Street Corp | 2024-12-31 | 1.2 M | Ikarian Capital, Llc | 2024-12-31 | 1.1 M | Sphera Funds Management Ltd. | 2024-12-31 | 1 M | Jpmorgan Chase & Co | 2024-12-31 | 928.6 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-12-31 | 871.5 K | Two Sigma Advisers, Llc | 2024-12-31 | 800.8 K | Renaissance Technologies Corp | 2024-12-31 | 624.5 K | Blackrock Inc | 2024-12-31 | 4.5 M | Citadel Advisors Llc | 2024-12-31 | 4.5 M |
Ventyx Fundamentals
| Return On Equity | -0.54 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | (106.23 M) | ||||
| Shares Outstanding | 71.13 M | ||||
| Shares Owned By Insiders | 4.46 % | ||||
| Shares Owned By Institutions | 84.50 % | ||||
| Number Of Shares Shorted | 6.62 M | ||||
| Price To Book | 0.39 X | ||||
| EBITDA | (148.45 M) | ||||
| Net Income | (135.12 M) | ||||
| Cash And Equivalents | 250.45 M | ||||
| Cash Per Share | 4.92 X | ||||
| Total Debt | 10.79 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.27 X | ||||
| Book Value Per Share | 3.57 X | ||||
| Cash Flow From Operations | (130.87 M) | ||||
| Short Ratio | 5.74 X | ||||
| Earnings Per Share | (1.97) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 79 | ||||
| Beta | 0.58 | ||||
| Market Capitalization | 100.29 M | ||||
| Total Asset | 276.56 M | ||||
| Retained Earnings | (554.31 M) | ||||
| Working Capital | 216.85 M | ||||
| Net Asset | 276.56 M |
About Ventyx Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ventyx Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventyx Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventyx Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ventyx Stock Analysis
When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.